Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Search Criteria
Gene/CloneSpeciesStageAnatomy ItemExperimenter
pax3xenopus   

Too many results?Too few results?

Experiment details for pax3



BMP antagonists and FGF signaling contribute to different domains of the neural plate in Xenopus.

Gene Clone Species Stages Anatomy
pax3 xenopus NF stage 20 forebrain , midbrain , hatching gland , anterior neural fold , neural tube

Display additional annotations [+]
  Fig. 7. Xenopus ectodermal explants and ventralized embryos do not express neural border markers. Uninjected control X. laevis embryos, β-catenin morphants, and animal caps cut from blastula stage uninjected or noggin-injected embryos were cultured to stage 20 and assayed for expression of the neural border markers pax3, hairy2a, and zic2, and the neural crest marker slug. Expression of these genes was not detected in animal caps or β-catenin morphants (of β-catenin morphants, 0% expressed hairy2a (n = 14), pax3 (n = 15), and zic2 (n = 14), while 6% expressed slug weakly (n = 16). All four genes had some expression in animal caps cut from embryos injected with 1 pg of noggin mRNA (63% for hairy2a, n = 8; 50% for pax3, n = 10; 79% for slug, n = 14; and 67% for zic2, n = 9) . The epidermal marker cytokeratin is strongly expressed in β-catenin morphants but excluded from the blastopore. Cytokeratin is strongly expressed in both injected and uninjected animal caps, but was somewhat weaker in noggin-injected animal caps. Embryos are shown in dorsal views with anterior to the left.